Showing results (31-40 of 94) with videos related to
Sort By:
Pageof 10
The Journal of Rheumatology|July 17, 2014
Rilonacept for gout flare prevention in patients receiving uric acid-lowering therapy: results of RESURGE, a phase III, international safety studyJohn S Sundy, H Ralph Schumacher, Alan Kivitz, et al.Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2024
Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo-Controlled, Phase 3 StudyAtul Deodhar, Jerzy Supronik, Alan Kivitz, et al.Clinical Therapeutics|December 13, 2006
Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trialAlan Kivitz, Steven Cohen, James Edward Dowd, et al.Arthritis Research & Therapy|December 24, 2017
Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3Karel Pavelka, Alan Kivitz, Eva Dokoupilova, et al.Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Healthcare Providers Face Numerous Challenges in Treating Patients with Psoriasis: Results from a Mixed-Methods StudySuzanne Murray, Jeffrey Crowley, Melinda J Gooderham, et al.The Journal of Rheumatology|April 15, 2024
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)Gerd R Burmester, Filip Van den Bosch, John Tesser, et al.ACR Open Rheumatology|January 6, 2023
Selective Inhibition of the MK2 Pathway: Data From a Phase IIa Randomized Clinical Trial in Rheumatoid ArthritisDavid Gordon, Alan Kivitz, Atul Singhal, et al.RMD Open|June 14, 2022
Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2Andrew J K Ostor, Ahmed M Soliman, Kim A Papp, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 30, 2023
A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid ArthritisMatthew C Baker, Sarah Kavanagh, Stanley Cohen, et al.Journal of Clinical Pharmacology|September 8, 2016
Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTAHisham Abdallah, Joy C Hsu, Peng Lu, et al.Pageof 10